Coventry Man Joins Cancer Trial – Dad & Uncle Lost
- Dean Burton, a 56-year-old plumber from Coventry, is participating in a Cancer Research UK clinical trial investigating a link between chronic heartburn and esophageal cancer, following the recent...
- Dean Burton's decision to join the BEST4 trial stems from a deeply personal experience.
- "My family's experience [of cancer] has brought home to me how critically important it is indeed to catch things early," Burton stated in an interview with the Coventry...
“`html
Coventry Man Joins £6.4M Cancer Screening Trial After Family Loss
Table of Contents
Dean Burton, a 56-year-old plumber from Coventry, is participating in a Cancer Research UK clinical trial investigating a link between chronic heartburn and esophageal cancer, following the recent deaths of his father and uncle to cancer.
Published: November 21, 2023
The Personal Toll of Cancer
Dean Burton’s decision to join the BEST4 trial stems from a deeply personal experience. In August 2023,his father,Graham Burton,72,died of stomach cancer while awaiting further diagnostic tests Coventry Telegraph.Just nine days later, his uncle succumbed to prostate cancer, compounding the family’s grief.
“My family’s experience [of cancer] has brought home to me how critically important it is indeed to catch things early,” Burton stated in an interview with the Coventry Telegraph. He has managed chronic heartburn with medication for over 30 years, and the trial offers a potential link between his long-term condition and the risk of esophageal cancer.
Understanding the BEST4 Trial
the BEST4 (Barrett’s and Esophageal Surveillance Trial 4) is a £6.4 million clinical trial led by Cancer Research UK, aiming to improve early detection of esophageal cancer. The trial focuses on individuals experiencing persistent heartburn, a common symptom that can sometimes indicate Barrett’s esophagus - a condition that increases the risk of esophageal adenocarcinoma Cancer Research UK.
Esophageal cancer is often diagnosed at a late stage, leading to poorer outcomes. the BEST4 trial seeks to determine the most effective surveillance strategies for individuals at higher risk, possibly saving lives through earlier intervention.
heartburn and Esophageal Cancer: The Connection
Chronic heartburn, also known as acid reflux, occurs when stomach acid frequently flows back into the esophagus. While frequently enough manageable with medication, persistent heartburn can lead to Barrett’s esophagus, where the normal lining of the esophagus is replaced by tissue similar to that of the intestine Mayo Clinic.
Barrett’s esophagus itself doesn’t cause symptoms, but it substantially increases the risk of developing esophageal adenocarcinoma, a type of esophageal cancer. The BEST4 trial aims to identify the best way to monitor individuals with Barrett’s esophagus and detect any cancerous changes early on.
According to cancer Research UK, in 2021, there were 9,858 new cases of esophageal cancer in the UK.
What Does This Mean for You?
If you experience persistent heartburn, especially if it’s been ongoing for several years, it’s crucial to consult with your doctor. While heartburn is common and often benign, it’s important to rule out underlying conditions like Barrett’s esophagus.
the BEST4 trial is currently recruiting participants. Individuals aged 50-75 with persistent heartburn symptoms are encouraged to inquire with their GP about potential eligibility. More information about the trial can be found on the